Pages that link to "Q37689391"

The following pages link to Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. (Q37689391):

Displaying 39 items.

• Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine (Q26864460) (← links)
• CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance (Q27324358) (← links)
• Childhood acute lymphoblastic leukemia: Integrating genomics into therapy (Q28080463) (← links)
• Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration (Q28087637) (← links)
• IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study (Q28555124) (← links)
• ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. (Q35160808) (← links)
• Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. (Q35171267) (← links)
• IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias (Q36105608) (← links)
• Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line (Q36502518) (← links)
• Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia (Q36682938) (← links)
• Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes (Q37043504) (← links)
• Developmental gene networks: a triathlon on the course to T cell identity (Q38233767) (← links)
• Genomics in acute lymphoblastic leukaemia: insights and treatment implications (Q38381463) (← links)
• Shaping of the tumor microenvironment: Stromal cells and vessels. (Q38385705) (← links)
• Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons (Q38790957) (← links)
• JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. (Q38796883) (← links)
• Ruxolitinib induces autophagy in chronic myeloid leukemia cells. (Q38841623) (← links)
• Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment (Q38856941) (← links)
• The genetics and mechanisms of T cell acute lymphoblastic leukaemia (Q38906841) (← links)
• Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors (Q39443070) (← links)
• Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity (Q40502119) (← links)
• The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation (Q45057541) (← links)
• The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. (Q45062542) (← links)
• TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia (Q47704064) (← links)
• Interleukin-7 in the transition of bone marrow progenitors to the thymus. (Q51826827) (← links)
• Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice. (Q53014072) (← links)
• Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations. (Q54977480) (← links)
• IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update (Q57566523) (← links)
• STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells (Q58762852) (← links)
• Clinical and molecular characterization of early T-cell precursor acute lymphoblastic leukemia: Two cases report and literature review (Q60928905) (← links)
• The role of polycomb repressive complex 2 in early T-cell precursor acute lymphoblastic leukemia (Q62633484) (← links)
• Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia (Q88044886) (← links)
• IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia (Q90147881) (← links)
• Flip the coin: IL-7 and IL-7R in health and disease (Q91345401) (← links)
• The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL (Q91620670) (← links)
• The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia (Q92137414) (← links)
• A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia (Q92237370) (← links)
• Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia (Q92941579) (← links)
• Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia (Q93027164) (← links)